It was observed that there were significant differences in the FAS between Group L and Group C at 4 h and 24 h, but no significant difference between Group L and Group C at 48 h and 72 h, indicating that IPC using lobaplatin could induce hyperalgesia in cancer patients. This evidence concerns the gene FAS and cancer.